Efficacy and Safety of DWC202404 and DWC202314 in Patients With Hypertension
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 192 participants.
Also called NCT06682000
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 192 participants
- Registry
-
NCT06682000
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT06682000. Randomized; double masking; primary purpose treatment. Start 2025-01-20 (actual); primary completion 2025-10-02 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy and Safety of DWC202404 and DWC202314 in Patients With Hypertension
- Condition
- Hypertension
- Condition
- Essential Hypertension
- Intervention (Drug)
- DWC202404, DWC202314
- Intervention (Drug)
- DWC202404, DWC202314P
- Lead sponsor
- Daewoong Pharmaceutical Co. LTD.
Record details
- Record id
cardio:ct-nct06682000- Content hash
5fb9d307974cb1408deecf2f2e6e8f9b0bf703717338b783d54f036a98f3b42d